Arunaya Organics Announces Financial Results for Half and Year Ended March 31, 2026; Board Approves Committee Changes
Arunaya Organics Limited announced its audited financial results for the half and year ended March 31, 2026, following a meeting of its Board of Directors held on May 30, 2026. The Board approved the results and also addressed key governance matters, including the reconstitution of its Stakeholder Relationship Committee and the appointment of a Secretarial Auditor.During the audit of the financial results, the appointed auditors, Abhishek Kumar & Associates, issued a report noting that certain payments for import transactions and receivables from export transactions have remained unpaid for a period exceeding six months from their due dates. The report highlighted that the existence of these long-outstanding payables and receivables may impact the company's working capital management and potential creditworthiness.
Financial Highlights and Audit Qualifications
The Standalone Statement of Profit and Loss for the year ended March 31, 2026, showed a Total Income of 10187.6s Lakhs. Total expenses were reported at 9E73.21 Lakhs, leading to a Profit for the Period from Continuing Operations of 37r.85 Lakhs.The company's financial position as of March 31, 2026, showed total outstanding liabilities of 6 t 1f.88 Lakhs, matched by total assets of 9.005.53 Lakhs.
A key observation from the audit pertains to the utilization of Initial Public Offer (IPO) proceeds. The company had originally allotted Rs. 1178.95 Lakhs for setting up a new manufacturing facility at Dahej, Bharuch. Of this amount, Rs. 278.95 Lakhs was utilized, while a total of Rs. 900.00 Lakhs was noted as pending or utilized for other purposes, including establishing Fixed Deposits (FDR) and obtaining Overdraft limits from Indian Overseas Bank for general business activities.
Corporate Governance Updates
During the board meeting, Arunaya Organics Limited formally reconstituted its Stakeholder Relationship Committee (SRC). Mr. Vinod Brijmohandas Agrawal was introduced as a member of the Committee, bringing the updated composition to the following structure:| Sr. No. | Name | Designation | Nature of Directorship |
|---|---|---|---|
| 1 | Mr. Ashokbhai Divanchand Agrawal | Chairman | Non-Executive Director |
| 2 | Mr. Umesh Krishnankutty Menon | Member | Non-Executive Independent Director |
| 3 | Mrs. Amita Chhaganbhai Pragada | Member | Non-Executive Independent Director |
| 4 | Mr. Vinod Brijmohandas Agrawal | Member | Managing Director |
In addition to the SRC reconstitution, the company also appointed M/s. G R Shah & Associates, Practising Company Secretaries, as the Secretarial Auditors for the financial year 2025-26.
Statement of Deviation in Funds Utilization
The company released details regarding the utilization of the Rs. 3,050.80 Lakhs raised through its Initial Public Issue (IPO) on May 7, 2025. The total funds utilized as of March 31, 2026, amounted to Rs. 2150.8 Lakhs.The utilization breakdown for the funds was as follows:
| Original Object | Original Allocation (Rs. in Lakhs) | Funds Utilized (Rs. in Lakhs) | Status |
|---|---|---|---|
| Setting up of New Manufacturing Facility | 1178.95 | 278.95 | Funds unutilized are invested in fixed deposits, against which an overdraft facility has been utilized. |
| To Meet Working Capital Requirements | 900.00 | 900.00 | Utilized fully. |
| General Corporate Purpose | 672.87 | 672.87 | Utilized fully. |
| Issue Related Expenses | 298.98 | 298.98 | Utilized fully. |
| Total | 3050.80 | 2150.80 | 900.00 Lakhs unutilized. |
The company confirmed that the Statement of Deviation/Variation in utilization of funds showed no deviation regarding the use of proceeds.
ARUNAYA Stock Price Movement
Arunaya Organics Limited shares slipped 4.86% on Friday, settling at ₹21.55. The equity saw a total traded volume of 58,000 shares throughout the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.